Menopause and coronary heart disease. The Framingham Study

Area of Science:

• Cardiovascular Medicine
• Women's Health
• Endocrinology

Background:

• Coronary heart disease (CHD) incidence rises post-menopause.
• Menopause is associated with increased severity of cardiovascular events.
• Framingham Heart Study data provides long-term follow-up on cardiovascular health.

Purpose of the Study:

• To investigate the impact of menopause on coronary heart disease incidence and severity.
• To compare cardiovascular event rates in premenopausal versus postmenopausal women.
• To examine the influence of natural versus surgical menopause on CHD risk.

Main Methods:

• Longitudinal cohort study of 2873 women.
• 24-year follow-up period.
• Analysis of CHD incidence and event severity stratified by menopausal status and age.

Main Results:

• No premenopausal women experienced myocardial infarction or CHD death.
• CHD events were common in postmenopausal women, with 40% presenting severely even under age 55.
• Incidence rates in women aged 45-54 were more than double premenopausal rates, regardless of menopause type (natural or surgical).
• Surgical menopause showed excess incidence irrespective of oophorectomy.
• Hormone therapy in postmenopausal women doubled CHD risk.

Conclusions:

• Menopause is a critical period for increased coronary heart disease risk and severity.
• Age at menopause and menopausal status are significant determinants of cardiovascular outcomes.
• Further research is needed on the cardiovascular implications of hormone replacement therapy.